Supplemental Table 4

<b>Supplemental Tabl</b><b>e 4</b><b>: ENRICHR pathway analysis table for McAdam et.al.</b> Due to the length of this table, it is provided as an Excel file (Table_S4.xlsx). The full list of KEGG 2021 non-disease enriched pathways (p&lt;0.05) resulting from ENRICHR analysis for Figures 4E, 4G, 5C, S2 and S3 are provided. For each, the enriched pathway, overlap, p-value, adjusted p-value, odds ratio, combined score and genes appearing in the indicated pathways are provided. mRNA lists used for ENRICHR analysis are provided in the “mRNA target lists” tab.

**补充表4：针对McAdam等人研究的ENRICHR通路分析表**
鉴于本表格篇幅较长，其以Excel文件（Table_S4.xlsx）形式提供。针对图4E、4G、5C、S2及S3开展ENRICHR分析后，所得的京都基因与基因组百科全书（KEGG）2021版非疾病富集通路（p<0.05）完整列表已随本文件提供。针对每条富集通路，本文件均提供了通路名称、重叠基因数、p值、校正后p值、比值比、联合得分以及对应通路包含的基因信息。用于本次ENRICHR分析的mRNA列表已收录于「mRNA靶标列表」工作表中。